Validated instruments on the platform
Beacon delivers and scores standardized patient-reported outcome instruments as part of continuous longitudinal monitoring. All instruments are administered to patients and scored according to published protocols - results are summarized for clinician review, not used to trigger autonomous actions.
The standard PROMIS-29 v2.1 profile is Beacon's platform default for all pain clinic deployments. Seven core domains administered as 4-item short forms, plus Pain Intensity NRS. Administered on the Beacon patient app and scored automatically, with domain-level T-scores available in the clinician dashboard for longitudinal trend review.
Deployed at both active Beacon clinical sites. Domain T-scores are presented longitudinally for clinician interpretation - not used to direct or automate treatment decisions.
What the data shows
The Veterans chronic pain pilot was Beacon's first prospective feasibility study in a real-world population. It examined whether patients with chronic pain would engage with continuous wearable monitoring between clinic visits over a sustained period.
The pilot demonstrated feasibility of longitudinal biopsychosocial monitoring in real-world conditions - patients sustained engagement with wearable monitoring and structured symptom reporting across multiple weeks. Participating clinicians reported improved visibility into patient-reported pain, sleep, and activity trends, supported by continuous wearable signal data. The pilot measured engagement and signal collection, not clinical efficacy.
How a collaboration works
Beacon operates as the data infrastructure layer. The clinical site or academic center provides the patient population, the clinical expertise, and the research design. Publication rights remain with the site.
Interested in a research collaboration?
If you are a clinician-scientist, academic medical center, or foundation looking to study longitudinal pain monitoring - reach out. We are early and selective with partnerships.